Traveka Wealth’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$435K Buy
4,744
+80
+2% +$7K 0.14% 109
2026
Q1
$398K Buy
4,664
+366
+9% +$32.6K 0.15% 103
2025
Q4
$340K Sell
4,298
-681
-14% -$53.4K 0.14% 120
2025
Q3
$398K Buy
4,979
+182
+4% +$15.5K 0.18% 95
2025
Q2
$436K Buy
4,797
+140
+3% +$12.8K 0.23% 73
2025
Q1
$436K Buy
4,657
+178
+4% +$15.9K 0.24% 70
2024
Q4
$407K Buy
+4,479
New +$427K 0.22% 75
2024
Q1
Sell
-4,327
Closed -$345K 137
2023
Q4
$345K Buy
+4,327
New +$325K 0.17% 72

Other funds holding CL

Traveka Wealth's CL Position: Q2 2026 in Review

Traveka Wealth increased its Colgate-Palmolive (CL) stake by 1.7% in Q2 2026, buying an estimated $7K and bringing the position to 4,744 shares worth $435K. The position accounts for 0.14% of the portfolio, ranked #109.

Traveka Wealth first reported a position in CL in Q4 2023 and has held it in 8 quarters since. The position peaked at $436K in Q1 2025. 954 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Traveka Wealth held 4,744 shares of Colgate-Palmolive worth $435K as of Q2 2026.
  • Traveka Wealth bought 80 Colgate-Palmolive shares in Q2 2026, an estimated $7K.
  • Colgate-Palmolive made up 0.14% of Traveka Wealth's portfolio in Q2 2026, its #109 holding.
  • Traveka Wealth first reported a position in Colgate-Palmolive in Q4 2023 and has held it in 8 quarters since.
  • Traveka Wealth's Colgate-Palmolive position peaked at $436K in Q1 2025.
  • 954 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Traveka Wealth's 13F filing for Q2 2026, filed 21 Jul 2026.